Use of ECMO in Acute MI
This trial is active, not recruiting.
|Condition||ecmo and acute mi|
|Sponsor||Johann Wolfgang Goethe University Hospitals|
|Start date||January 2003|
|End date||December 2006|
|Trial size||60 participants|
|Trial identifier||NCT00425685, ECMO and AMI, Use of ECM in acute MI|
ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.
|Observational model||defined population|
Male or female participants from 17 years up to 90 years old.
Inclusion Criteria: - Acute MI Exclusion Criteria: - Contraindication against ECMO
|Official title||Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures|
|Principal investigator||Farhad Bakhtiary, MD|
|Description||Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.|
Call for more information